SanBio Co (TSE:4592) Cash-to-Debt : 6.70 (As of Jan. 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. SanBio Co's cash to debt ratio for the quarter that ended in Jan. 2024 was 6.70.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, SanBio Co could pay off its debt using the cash in hand for the quarter that ended in Jan. 2024.

The historical rank and industry rank for SanBio Co's Cash-to-Debt or its related term are showing as below:

TSE:4592' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.02 Med: 3.27 Max: 7.22
Current: 6.7

During the past 11 years, SanBio Co's highest Cash to Debt Ratio was 7.22. The lowest was 1.02. And the median was 3.27.

TSE:4592's Cash-to-Debt is ranked worse than
50.37% of 1489 companies
in the Biotechnology industry
Industry Median: 6.91 vs TSE:4592: 6.70

SanBio Co Cash-to-Debt Historical Data

The historical data trend for SanBio Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

SanBio Co Cash-to-Debt Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Cash-to-Debt

Get a 7-Day Free Trial

3.41

3.12

1.81

7.22

6.70

SanBio Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Cash-to-Debt	Get a 7-Day Free Trial															7.22	6.56	5.79	5.20	6.70

Competitive Comparison of SanBio Co's Cash-to-Debt

For the Biotechnology subindustry, SanBio Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SanBio Co's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where SanBio Co's Cash-to-Debt falls into.

SanBio Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

SanBio Co's Cash to Debt Ratio for the fiscal year that ended in Jan. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4454.716	/	(268	+	397)
	=	6.70

SanBio Co's Cash to Debt Ratio for the quarter that ended in Jan. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4454.716	/	(268	+	397)
	=	6.70

SanBio Co (TSE:4592) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

SanBio Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of SanBio Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

SanBio Co (TSE:4592) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

SNBIF:USA

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines